Ahmad Y, Shelmerdine J, Bodill H, Lunt M, Pattrick MG, Teh LS, Bernstein RM, Walker MG, Bruce IN: Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology (Oxford). 2007, 46: 983-988. 10.1093/rheumatology/kem002.
Article
CAS
Google Scholar
Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, Kuller LH: Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 1999, 42: 51-60. 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D.
Article
CAS
Google Scholar
Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE: Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003, 349: 2399-2406. 10.1056/NEJMoa035471.
Article
CAS
Google Scholar
de Leeuw K, Freire B, Smit AJ, Bootsma H, Kallenberg CG, Bijl M: Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. Lupus. 2006, 15: 675-682. 10.1177/0961203306069972.
Article
CAS
Google Scholar
Merrell M, Shulman LE: Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis. 1955, 1: 12-32. 10.1016/0021-9681(55)90018-7.
Article
CAS
Google Scholar
Kasitanon N, Magder LS, Petri M: Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore). 2006, 85: 147-156. 10.1097/01.md.0000224709.70133.f7.
Article
Google Scholar
Funauchi M, Shimadzu H, Tamaki C, Yamagata T, Nozaki Y, Sugiyama M, Ikoma S, Kinoshita K: Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center. Rheumatol Int. 2007, 27: 243-249.
Article
CAS
Google Scholar
Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT: Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008, 35: 2152-2158. 10.3899/jrheum.080214.
Article
Google Scholar
Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF: Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum. 2011, 63: 1182-1189. 10.1002/art.30277.
Article
CAS
Google Scholar
Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, van Overeem Hansen G, Skaarup B, Hansen TM, Podenphant J, Halberg P: A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol. 1998, 17: 478-484. 10.1007/BF01451283.
Article
CAS
Google Scholar
Chambers SA, Allen E, Rahman A, Isenberg D: Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford). 2009, 48: 673-675. 10.1093/rheumatology/kep062.
Article
Google Scholar
Rabbani MA, Habib HB, Islam M, Ahmad B, Majid S, Saeed W, Shah SM, Ahmad A: Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus. 2009, 18: 848-855. 10.1177/0961203309103410.
Article
Google Scholar
Wadee S, Tikly M, Hopley M: Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford). 2007, 46: 1487-1491. 10.1093/rheumatology/kem180.
Article
CAS
Google Scholar
Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A: Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. J Rheumatol. 2004, 31: 713-719.
Google Scholar
Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, et al: Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006, 54: 2550-2557. 10.1002/art.21955.
Article
CAS
Google Scholar
Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA: Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002, 61: 409-413. 10.1136/ard.61.5.409.
Article
PubMed Central
CAS
Google Scholar
Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G: Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000, 27: 685-691.
CAS
Google Scholar
Reveille JD, Bartolucci A, Alarcon GS: Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990, 33: 37-48. 10.1002/art.1780330105.
Article
CAS
Google Scholar
Abu-Shakra M, Urowitz MB, Gladman DD, Gough J: Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol. 1995, 22: 1265-1270.
CAS
Google Scholar
Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR: Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002, 61: 1065-1070. 10.1136/ard.61.12.1065.
Article
PubMed Central
CAS
Google Scholar
Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, Atzeni F, Piccoli A, Todesco S: Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006, 119: 700-706. 10.1016/j.amjmed.2005.11.034.
Article
Google Scholar
Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverval A, Wedel H, Whincup P, Wilhelmsen L, Graham IM: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003, 24: 987-1003. 10.1016/S0195-668X(03)00114-3.
Article
CAS
Google Scholar
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277. 10.1002/art.1780251101.
Article
CAS
Google Scholar
Liang MH, Socher SA, Roberts WN, Esdaile JM: Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum. 1988, 31: 817-825. 10.1002/art.1780310701.
Article
CAS
Google Scholar
Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996, 39: 363-369. 10.1002/art.1780390303.
Article
CAS
Google Scholar
Gustafsson J, Gunnarsson I, Borjesson O, Pettersson S, Moller S, Fei GZ, Elvin K, Simard JF, Hansson LO, Lundberg IE, Larsson A, Svenungsson E: Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther. 2009, 11: R186-10.1186/ar2878.
Article
PubMed Central
Google Scholar
Heartscore. [http://www.heartscore.org]
Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, van Overeem Hansen G, Skaarup B, Hansen TM, Podenphant J, Halberg P: Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol. 1999, 28: 75-80. 10.1080/030097499442522.
Article
CAS
Google Scholar
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernandez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR: Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003, 82: 299-308. 10.1097/01.md.0000091181.93122.55.
Article
Google Scholar
Nived O, Jonsen A, Bengtsson AA, Bengtsson C, Sturfelt G: High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol. 2002, 29: 1398-1400.
Google Scholar
Shlipak MG, Weekley CC, Li Y, Hansson LO, Larsson A, Whooley M: Comparison of cardiovascular prognosis by 3 serum cystatin C methods in the heart and soul study. Clin Chem. 2011, 57: 737-745. 10.1373/clinchem.2010.158915.
Article
CAS
Google Scholar
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.
Article
CAS
Google Scholar
Faurschou M, Dreyer L, Kamper AL, Starklint H, Jacobsen S: Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken). 2010, 62: 873-880. 10.1002/acr.20116.
Article
Google Scholar
Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, Miccoli R, Del Prato S, Penno G: Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem. 2007, 53: 480-488. 10.1373/clinchem.2006.076042.
Article
CAS
Google Scholar
Hsu CY, Chertow GM, Curhan GC: Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int. 2002, 61: 1567-1576. 10.1046/j.1523-1755.2002.00299.x.
Article
Google Scholar
Risch L, Herklotz R, Blumberg A, Huber AR: Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001, 47: 2055-2059.
CAS
Google Scholar
Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007, 71: 239-244. 10.1038/sj.ki.5002042.
Article
CAS
Google Scholar
Lee M, Saver JL, Huang WH, Chow J, Chang KH, Ovbiagele B: Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis. Circ Cardiovasc Qual Outcomes. 2010, 3: 675-683. 10.1161/CIRCOUTCOMES.110.957696.
Article
Google Scholar
Wu CK, Lin JW, Caffrey JL, Chang MH, Hwang JJ, Lin YS: Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey). J Am Coll Cardiol. 2010, 56: 1930-1936. 10.1016/j.jacc.2010.04.069.
Article
CAS
Google Scholar
Svenungsson E, Cederholm A, Jensen-Urstad K, Fei GZ, de Faire U, Frostegard J: Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus. Scand J Rheumatol. 2008, 37: 352-359. 10.1080/03009740802007514.
Article
CAS
Google Scholar
Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J: C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010, 375: 132-140.
Article
Google Scholar
Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tygbjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, et al: Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. Jama. 2005, 294: 1799-1809.
CAS
Google Scholar
Kao AH, Wasko MC, Krishnaswami S, Wagner J, Edmundowicz D, Shaw P, Cunningham AL, Danchenko N, Sutton-Tyrrell K, Tracy RP, Kuller LH, Manzi S: C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis. Am J Cardiol. 2008, 102: 755-760. 10.1016/j.amjcard.2008.04.059.
Article
PubMed Central
CAS
Google Scholar
Toloza SM, Uribe AG, McGwin G, Alarcon GS, Fessler BJ, Bastian HM, Vila LM, Wu R, Shoenfeld Y, Roseman JM, Reveille JD: Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum. 2004, 50: 3947-3957. 10.1002/art.20622.
Article
Google Scholar
Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U, Witztum JL, Frostegard J: Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation. 2001, 104: 1887-1893. 10.1161/hc4101.097518.
Article
CAS
Google Scholar
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, PG DEG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4: 295-306. 10.1111/j.1538-7836.2006.01753.x.
Article
CAS
Google Scholar
Petri M: Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Lupus. 2010, 19: 419-423. 10.1177/0961203309360541.
Article
CAS
Google Scholar
Seleznick MJ, Fries JF: Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum. 1991, 21: 73-80. 10.1016/0049-0172(91)90040-7.
Article
CAS
Google Scholar
Kim WU, Min JK, Lee SH, Park SH, Cho CS, Kim HY: Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol. 1999, 17: 539-545.
CAS
Google Scholar